BioSpace News Archive

NovaBay® Pharmaceuticals, Inc. announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003 and of the NYSE American Company Guide pursuant to stockholders equity.

Biodexa Pharmaceuticals PLC announces its audited preliminary results for the year ended 31 December 2023.

Concord Medical Services Holdings Limited today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the “Annual Report”) with the U.S. Securities and Exchange Commission.

Legacy Medical Consultants (LMC) announces its newest product portfolio addition with the recent Q code approval for Reeva FT™, a terminally sterilized, full-thickness, dual-layered amnion/chorion allograft designed for covering and protection during advanced wound treatment.

CorMedix Inc. today announced that the Center for Medicare & Medicaid Services (CMS) has determined that DefenCath ® meets the criteria for a Transitional Drug Add-On Payment (TDAPA) in the anti-infective functional category, beginning on July 1, 2024.

PharmAla Biotech Holdings Inc. is pleased to announce that, further to its press release dated April 10, 2024 (the “ April 10 Release ”), the Company has closed its previously announced non-brokered private placement offering.

Stemtech Corporation is proud to announce that it is on track to achieve the CEO and Chairman’s goal of becoming cash flow positive.

TScan Therapeutics, Inc. today announced the closing of an underwritten public offering of 2,472,581 shares of its voting common stock at a public offering price of $7.1300 per share.

Cresilon Inc. today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons through several of the leading animal health and veterinary product suppliers in the U.S., including Covetrus, MWI Animal Health, and Patterson Veterinary Supply.

NeuroMetrix, Inc. announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital.